Boston Scientific beat expectations with its 1st-quarter earnings, but missed the sales mark, sending shares down this morning despite a boosted earnings outlook for the rest of the year.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/QUSmqy
Cap comentari:
Publica un comentari a l'entrada